- Investing Ideas
- Swedish Pharmaceuticals & Biotech Healthy potentially undervalued
Swedish Pharmaceuticals & Biotech Healthy potentially undervalued
Results
4
Companies which are potentially undervalued and in an acceptable financial position.
4 companies
Camurus
Market Cap: SEK 31.4b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 525.00
7D
-2.1%
1Y
4.0%
Swedish Orphan Biovitrum
Market Cap: SEK 153.6b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 444.00
7D
1.7%
1Y
51.2%
Bonesupport Holding
Market Cap: SEK 15.5b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 235.40
7D
-9.0%
1Y
-7.7%
Vitrolife
Market Cap: SEK 13.7b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 101.20
7D
-6.3%
1Y
-34.2%